Nuveen »

Kyverna Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.1M 234k 8.91
2025-03-31 $92k 48k 1.93

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Kyverna Therapeutics

Gilead Sciences
BlackRock
Bain Capital Life Sciences Investors
AIGH Capital Management
Deerfield Management Company
Vanguard Capital Management
T. Rowe Price Associates
Geode Capital Management
Insight Holdings
Morgan Stanley
Propel Bio Management
Woodline Partners
Millennium Management
Mbb Public Markets I
Adage Capital Partners GP

View all funds holding Kyverna Therapeutics